Stifel Financial’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
Stifel Financial's SBIO Position: Q3 2026 in Review
Stifel Financial increased its ALPS Medical Breakthroughs ETF (SBIO) stake by 84% in Q3 2026, buying an estimated $1.4M and bringing the position to 47,180 shares worth $2.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1828.
Stifel Financial first reported a position in SBIO in Q3 2019 and has held it in 15 quarters since. 77 funds tracked by Wall St. Rank hold SBIO as of Q3 2026.
- Stifel Financial held 47,180 shares of ALPS Medical Breakthroughs ETF worth $2.75M as of Q3 2026.
- Stifel Financial bought 21,532 ALPS Medical Breakthroughs ETF shares in Q3 2026, an estimated $1.4M.
- ALPS Medical Breakthroughs ETF made up ﹤0.01% of Stifel Financial's portfolio in Q3 2026, its #1828 holding.
- Stifel Financial first reported a position in ALPS Medical Breakthroughs ETF in Q3 2019 and has held it in 15 quarters since.
- 77 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2026.
Based on Stifel Financial's 13F filing for Q3 2026, filed 12 Nov 2026.